Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quipt Home Medical (QIPT) Change in Receivables (2020 - 2025)

Historic Change in Receivables for Quipt Home Medical (QIPT) over the last 6 years, with Q4 2025 value amounting to -$223000.0.

  • Quipt Home Medical's Change in Receivables fell 11509.82% to -$223000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$4.3 million, marking a year-over-year decrease of 16319.29%. This contributed to the annual value of -$2.6 million for FY2025, which is 17817.24% down from last year.
  • As of Q4 2025, Quipt Home Medical's Change in Receivables stood at -$223000.0, which was down 11509.82% from -$468000.0 recorded in Q3 2025.
  • In the past 5 years, Quipt Home Medical's Change in Receivables ranged from a high of $8.6 million in Q1 2024 and a low of -$3.5 million during Q1 2021
  • Over the past 5 years, Quipt Home Medical's median Change in Receivables value was -$483000.0 (recorded in 2021), while the average stood at $187800.0.
  • Over the last 5 years, Quipt Home Medical's Change in Receivables had its largest YoY gain of 81131.81% in 2023, and its largest YoY loss of 59041.92% in 2023.
  • Quarter analysis of 5 years shows Quipt Home Medical's Change in Receivables stood at -$498000.0 in 2021, then crashed by 59.64% to -$795000.0 in 2022, then tumbled by 150.82% to -$2.0 million in 2023, then soared by 174.07% to $1.5 million in 2024, then plummeted by 115.1% to -$223000.0 in 2025.
  • Its Change in Receivables stands at -$223000.0 for Q4 2025, versus -$468000.0 for Q3 2025 and -$2.5 million for Q2 2025.